CD274 and cancer: We demonstrated that suppressed protein N-glycosylation by metformin and low 2DG also reduced PD-L1 expression in MDA-MB-231 cells and PD-1 expression on Jurkat cells used as a model T cells, while partially maintaining their effector function, suggesting metformin and 2DG treatment as a potential adjunct therapy in the context of cancer immunotherapy.